Major depressive episode with psychotic features induced by pegylated interferon-α-2b and ribavirin treatment

International Clinical Psychopharmacology

Volumn 20, Issue 5, 2005, Pages 289-290

  Sockalingam, Sanjeev ^a,c   Balderson, Ken ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c 17 095 Victoria Wing ^*  (Canada)

Author keywords

Depression; Hepatitis C; Interferons; Psychotic disorder

Indexed keywords

CITALOPRAM; OLANZAPINE; PEGINTERFERON ALPHA2B; RIBAVIRIN; RISPERIDONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CAUCASIAN; DELUSION; DEPRESSION; HEPATITIS C; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALAISE; MALE; PARANOIA; PRIORITY JOURNAL; PSYCHOPATHY; PSYCHOSIS; SIDE EFFECT; SUICIDE ATTEMPT; WEIGHT REDUCTION;

ADULT; ANTIVIRAL AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; MALE; POLYETHYLENE GLYCOLS; PSYCHOSES, SUBSTANCE-INDUCED; RIBAVIRIN;

EID: 23944431892     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yic.0000170263.46008.54     Document Type: Article

References (6)

1. Greenberg DB, Jonasch E, Gadd MA, Ryan BF, Everett JR, Sober AJ, et al. (2000). Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Cancer 89:356-362.
2. Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J, et al. (2002). A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 7:942-947.
3. Horikawa N, Yamazaki T, Izumi N, Uchihara M (2003). Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. Gen Hosp Psychiatry 25:34-38.
4. Kalyoncu OA, Tan D, Mirsal H, Pektas O, Beyazyurek M (2005). Major depressive disorder with psychotic features induced by interferon- (treatment for hepatitis C in a polydrug abuser). J Psychopharmacol 19:102-105.
5. Nozaki O, Takagi C, Takaoka K, Takata T, Yoshida M (1997). Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Psychiatry Clin Neurosci 51: 175-180.
6. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, Rustgi V, et al. (1987). Psychiatric complications of long-term interferon alpha therapy. Arch Intern Med 147:1577-1580.